Basic Information
NEUROBION TABLET
TABLET, SUGAR COATED
Regulatory Information
SIN06258P
June 21, 1991
Pharmacy Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XA11DB
Company Information
PROCTER & GAMBLE (SINGAPORE ) PTE LTD
PROCTER & GAMBLE (SINGAPORE) PTE LTD
Active Ingredients
Detailed Information
Contraindications
**Contraindications** Neurobion must not be used in patients hypersensitive to any of the active ingredients or excipients of the product (see ‘Composition’ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). Neurobion coated tablets are not suitable for the treatment of children due to the high content of active ingredients.
Indication Information
**Indications** Neurobion is indicated for neurological and other disorders associated with disturbance of metabolic functions influenced by B complex vitamins, including diabetic polyneuropathy, alcoholic peripheral neuritis and post influenzal neuropathies. Neurobion is also recommended for the treatment of neuritis and neuralgia of the spinal nerves, especially facial paresis, cervical syndrome, low back pain, ischialgia.